Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07260799 · ClinicalTrials.gov registry record
Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer
A clinical trial of Serum Analytes, sponsored by Tasso.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07260799: Recruiting study of Serum Analytes, sponsored by Tasso.
NCT07260799 is a study of Serum Analytes that is actively recruiting participants, run by Tasso. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07260799, a study of Serum Analytes, is actively recruiting participants, sponsored by Tasso.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this single-visit study is to demonstrate the performance of capillary blood samples collected with the Tasso+ Serum Gel Capillary Blood Collection System compared to venous reference samples for downstream analyte testing at a clinical laboratory.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Tasso+ Serum Gel Capillary Blood Collection System
Study Locations (1)
Florida
- Celesta / American Research Labs - Atlantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-10-25 |
| Est. Completion | 2026-05-31 |
What NCT07260799 shows while recruiting
NCT07260799 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Serum Analytes appearing as the primary indexed condition, and to 1 intervention - of which Tasso+ Serum Gel Capillary Blood Collection System is the first listed.
NCT07260799 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07260799 about?
NCT07260799 is a clinical study titled "Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer". The purpose of this single-visit study is to demonstrate the performance of capillary blood samples collected with the Tasso+ Serum Gel Capillary Blood Collection System compared to venous reference samples for downstream analyte testing at a clinical laboratory.
What is the current status of trial NCT07260799?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-10-25. Estimated completion is 2026-05-31.
What conditions does trial NCT07260799 study?
This clinical trial studies the following conditions: Serum Analytes.
What interventions are being tested in trial NCT07260799?
The interventions under investigation include: Tasso+ Serum Gel Capillary Blood Collection System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07260799?
This trial is sponsored by Tasso, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07260799 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI